** Australia-listed shares of Fisher & Paykel Healthcare FPH.AX rise as much as 1.8% to A$31.39
** Morgan Stanley initiates coverage on medical equipment maker, rated 'equal-weight' on stock, price target set at A$34
** Brokerage sees solid earnings growth with favourable long-term outlook, supported by increased clinical adoption
** Brokerage hikes its PT for co's shares in New Zealand FPH.NZ to NZ$36.70 from NZ$36.30, seeing less material U.S. tariff impacts on co
** Fisher & Paykel's NZ shares up 0.3% at NZ$33.55